PARP1 and Huntington disease: We aimed at clarifying two main aspects: first, the effects of PARP inhibition by a different, commercially available drug on neuroprotection in HD, and second, to evaluate the impact of this compound on apoptotic and pyroptotic cell death in the striatum.